Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Usana Health Sciences (USNA) Gross Margin (2016 - 2025)

Historic Gross Margin for Usana Health Sciences (USNA) over the last 16 years, with Q3 2025 value amounting to 77.15%.

  • Usana Health Sciences' Gross Margin fell 32400.0% to 77.15% in Q3 2025 from the same period last year, while for Sep 2025 it was 79.18%, marking a year-over-year decrease of 16800.0%. This contributed to the annual value of 81.13% for FY2024, which is 3200.0% up from last year.
  • Per Usana Health Sciences' latest filing, its Gross Margin stood at 77.15% for Q3 2025, which was down 32400.0% from 78.72% recorded in Q2 2025.
  • Over the past 5 years, Usana Health Sciences' Gross Margin peaked at 83.07% during Q3 2021, and registered a low of 77.15% during Q3 2025.
  • Moreover, its 5-year median value for Gross Margin was 81.05% (2024), whereas its average is 80.62%.
  • Its Gross Margin has fluctuated over the past 5 years, first skyrocketed by 14800bps in 2021, then crashed by -32400bps in 2025.
  • Usana Health Sciences' Gross Margin (Quarter) stood at 81.51% in 2021, then dropped by -2bps to 79.63% in 2022, then increased by 2bps to 80.86% in 2023, then increased by 1bps to 81.95% in 2024, then decreased by -6bps to 77.15% in 2025.
  • Its Gross Margin stands at 77.15% for Q3 2025, versus 78.72% for Q2 2025 and 78.98% for Q1 2025.